Z-1775-2021 Class II Terminated

Recalled by Fujifilm Medical Systems U.S.A., Inc. — Lexington, MA

FDA device recall Z-1775-2021 was initiated by Fujifilm Medical Systems U.S.A., Inc. on Apr 30, 2021 and is designated Class II. Reason for recall: Software versions 6.0.4 to 6.2.1 using Advanced Reporting -possibility that a previously assigned internal patient database ID can be reused for a new patient. It was discovered that this value does… The recall status is terminated (terminated Jul 29, 2024). Affected quantity: 44 US and 4 OUS.

Recall details

Product Type
Devices
Report Date
Jun 9, 2021
Initiation Date
Apr 30, 2021
Termination Date
Jul 29, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44 US and 4 OUS

Product description

Synapse Cardiovascular (Synapse CV). Software Versions: 6.0 to 6.2.1 The Synapse Cardiovascular image is a management and reporting system

Reason for recall

Software versions 6.0.4 to 6.2.1 using Advanced Reporting -possibility that a previously assigned internal patient database ID can be reused for a new patient. It was discovered that this value does not increase when a patient merge activity is executed in a specific sequence

Distribution pattern

Worldwide distribution - US Nationwide distribution and the countries of Canada, Bermuda, Israel, Hadassah Medical Center.

Code information

Software Versions: 6.0 to 6.2.1

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1775-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1775-2021. Report a data issue: hello@regdatalab.com.